Metabolomics Market is growing with double digit CAGR of 13.2% upto 2023 | Top 3 Key players are Agilent Technologies, Danaher Corporation, Biocrates Life Sciences AG

The Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023. North America contributed the highest market share in 2017; while, Asia-Pacific is expected to experience the highest growth rate during the forecast period.

Download the Sample Report @ http://bit.ly/2L0wt8E

The report offers insights on drivers, restraints, and opportunities of the global metabolomics market. Surge in adoption of metabolomics in precision medicine and rise in R&D investments are expected to facilitate the market growth. In addition, technological advancements for auxiliary medical devices utilized for analysis of metabolomics and rise in demand of quality medications supplements the growth of the market. However, expensive medical devices and lack of effective data management for profiling of metabolomics restrain the market growth.

The report provides an extensive analysis of the global metabolomics market based on product & service, application, indication, and geography. Based on product & service, the report segments the market into metabolomics instruments and metabolomics bioinformatics tools & services. The application segment is further classified into biomarker discovery, toxicology testing, drug discovery, functional genomics, nutrigenomics, personalized medicine, and others. Based on indication, the report bifurcates the market into cancer, neurological disorders, cardiovascular disorders, inborn errors of metabolism, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The biomarker discovery segment contributed the highest market share in 2017, and will maintain its dominant share during the forecast period. Advancements in quantification methods & technologies along with rise in concerns regarding prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer would fuel the growth of this segment.

For More Inquiry @ http://bit.ly/2WWjw24

Key Findings of the report:
• The drug discovery segment is anticipated to witness the highest grow rate during the forecast period.
• The biomarker discovery segment generated the highest market share in 2017 and is expected to maintain its dominance in the during the forecast period.
• North America dominated the global metabolomics market in 2017.
• China would register the highest CAGR in the Asia-Pacific region.

North America held the major market share in 2017, owing to surge in R&D investments and availability of advanced healthcare facilities. In addition, rise in usage of experimental medicines and increase in adoption of metabolomics for precision medicine fuel the growth. However, Asia-pacific would grow at the highest CAGR during the forecast period owing to increase in adoption of metabolomics in medical research and increase in government initiatives for finding cost-effective treatments for chronic diseases.

The key companies analyzed in the report include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation, Bruker Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc., Shimadzu Corporation, Bio-Rad Laboratories, Inc., Waters Corporation, and Thermo Fisher Scientific Inc.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.